Johnson & Johnson vaccine

COUNTY RESUMES USE OF JOHNSON AND JOHNSON VACCINE

Photo: An employee at the County Psychiatric Hospital gets her first dose of COVID-19 vaccine in December

By Katie Cadiao, County of San Diego Communications Office

April 28, 2021 (San Diego) -- The County is resuming vaccinations with the Johnson & Johnson vaccine after the California Department of Public Health gave the green light to do so over the weekend.

COUNTY PAUSES USE OF JOHNSON & JOHNSON VACCINES DUE TO RARE BLOOD CLOTTING COMPLICATION

By Miriam Raftery

Creative Commons image by NC via Bing

April 13, 2021 (San Diego) – San Diego County today announced that it will immediately pause use of the Johnson & Johnson COVID-19 vaccine “out of an abundance of caution.”  

The county’s action comes after the U.S. Centers for Disease Control and the Calif. Dept. of Public Health advised pausing the vaccine after six women between ages 16 and 48 developed a rare, severe type of blood clot called cerebral venous sinus thrombosis which can cause stroke-like illness, NPR reports.  The clots occurred one to two weeks after receiving the vaccine.

Over 6.8 million doses of the Johnson & Johnson vaccine have been administered in the U.S., so the serious clotting complication appears to have occurred in approximately one in a million cases.

COVID CASES DROP, JOHNSON & JOHNSON VACCINES ARRIVE IN SAN DIEGO

By Miriam Raftery

Photo: San Diego County

March 9, 2021 (San Diego) – The COVID-19 scenario is improving in San Diego County. On March 7, the county reported 307 new cases, no deaths, and a positive testing rate of just 3 percent – all significantly lower than in recent weeks.

That drop is no doubt due in part to the fact that 12.7% of San Diegans age 16 and up are now fully immunized, and nearly 24% of those eligible have received at least one shot. 

Now, arrival of the new Johnson & Johnson vaccine in our region will make it easier to get more people vaccinated. The J&J vaccine requires just one shot and can be stored at normal refrigerator temperatures, unlike Pfizer and Moderna vaccines, which require two shots and very cold storage.

AFTER FDA APPROVES JOHNSON & JOHNSON COVID-19 VACCINE, BIDEN INVOKES DEFENSE PRODUCTION ACT TO SPEED UP MANUFACTURING

By Miriam Raftery
 
Photo via National Institute of Allergy and Infectious Diseases
 
March 2, 2021 (Washington D.C.) – The U.S. Food & Drug Administration has approved a COVID-19 vaccine by Johnson & Johnson (J&J). To expedite getting Americans vaccinated as quickly as possible, President Joe Biden has invoked the Defense Production Act.